Cover Arzneimittelreport 2015First analysis of expenditure on cytostatic drugs in statutory health insurance.
Contact:
Prof. Dr. Gerd Glaeske (verstorben)
For the fifteenth time, the team of authors around Gerd Glaeske and Christel Schicktanz published the BARMER GEK Pharmaceutical Report 2015. By analysing the representative secondary data of prescriptions, expenditures and regional distributions of 8.6 million BARMER GEK insured, the pharmaceutical provision has been depicted convincingly. Special attention was drawn to the areas of supply where there is potential for improvement, i.e. drugs with unnecessary risks, preparations that are too frequently or too seldom prescribed as well as drugs with unnecessary costs.
Download:
BARMER GEK Arzneimittelreport 2015
Power Point Presentation at the press conference by Prof. Glaeske
Contact:
Prof. Dr. Gerd Glaeske (verstorben)
